Clinical trial
A Phase I Study of Irinotecan in Patients With Refractory Solid Tumors Who Are Concomitantly Receiving Anticonvulsants
NCT00008424 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I Study of Irinotecan in Patients With Refractory Solid Tumors Who Are Concomitantly Receiving Anticonvulsants
- Lead sponsor
- Children's Oncology Group
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- October 31, 2000
- Completion date
- September 30, 2006
- Enrollment
- 7 (actual)
- Sites
- 51
Conditions
As the registry lists them; a condition with its own page is linked.
unspecified childhood solid tumor, protocol specific